Percutaneous Pulmonary Angioplasty for Patients With Takayasu Arteritis and Pulmonary Hypertension

J Am Coll Cardiol. 2022 Apr 19;79(15):1477-1488. doi: 10.1016/j.jacc.2022.01.052.


Background: Percutaneous transluminal pulmonary angioplasty (PTPA) is a treatment modality for chronic thromboembolic pulmonary hypertension, but whether it can be applied to Takayasu arteritis-associated pulmonary hypertension (TA-PH), another chronic obstructive pulmonary vascular disease, remains unclear.

Objectives: This study sought to investigate the efficacy and safety of PTPA for TA-PH.

Methods: Between January 1, 2016, and December 31, 2019, a total of 50 patients with TA-PH who completed the PTPA procedure (the PTPA group) and 21 patients who refused the PTPA procedure (the non-PTPA group) were prospectively enrolled in this cohort study. The primary outcome was all-cause mortality. The safety outcomes included PTPA procedure-related complications.

Results: Baseline characteristics and medical therapies were similar between the PTPA group and the non-PTPA group. During a mean follow-up time of 37 ± 14 months, deaths occurred in 3 patients (6.0%) in the PTPA group and 6 patients (28.6%) in the non-PTPA group, contributing to the 3-year survival rate of 93.7% in the PTPA group and 76.2% in the non-PTPA group (P = 0.0096 for log-rank test). The Cox regression model showed that PTPA was associated with a significantly reduced hazard of all-cause mortality in TA-PH patients (HR: 0.18; 95% CI: 0.05-0.73; P = 0.017). No periprocedural death occurred. Severe complications requiring noninvasive positive pressure ventilation occurred in only 1 of 150 total sessions (0.7%).

Conclusions: PTPA tended to be associated with a reduced risk of all-cause mortality with acceptable safety profiles and seemed to be a promising therapeutic option for TA-PH patients.

Keywords: Takayasu arteritis; efficacy; percutaneous transluminal pulmonary angioplasty; pulmonary hypertension; safety.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angioplasty / adverse effects
  • Angioplasty / methods
  • Cohort Studies
  • Humans
  • Hypertension, Pulmonary* / etiology
  • Hypertension, Pulmonary* / therapy
  • Pulmonary Arterial Hypertension*
  • Retrospective Studies
  • Takayasu Arteritis* / complications
  • Takayasu Arteritis* / diagnosis
  • Takayasu Arteritis* / therapy
  • Treatment Outcome